CDMO PharmaLogic takes majority stake in Norway's Agilera to boost global radiopharma footprint
Contract manufacturer PharmaLogic is picking up a majority stake in Norway’s Agilera Pharma. The move forms part of the Florida-based CDMO’s plan to position itself as a global leader in radiopharmaceutical therapies.
Contract manufacturer PharmaLogic is picking up a majority stake in Norway’s Agilera Pharma. The move forms part of the Florida-based CDMO’s plan to position itself as a global leader in radiopharmaceutical therapies.
